您的位置: 首页 > 农业专利 > 详情页

PROTEASOME MODULATION FOR TREATMENT OF CORNEAL DISORDERS
专利权人:
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
发明人:
Fawzia Bardag-Gorce
申请号:
US15775728
公开号:
US20180369316A1
申请日:
2016.11.11
申请国别(地区):
US
年份:
2018
代理人:
摘要:
Disclosed herein are methods and compositions useful for preventing or reducing corneal haze of opacification resulting from Limbal Stem Cell Deficiency (LSCD). The invention comprises a method of preventing or treating corneal opacification, comprising administering to a subject a sufficient amount of a proteasome modulator. The invention also comprises a method of preventing or treating corneal opacification, comprising administering to a subject a sufficient amount of a proteasome modulator. In addition, the invention comprises a method of administering to a subject suffering from corneal opacification with a sufficient amount of proteasome modulator, resulting in reduction of Keratin proteins in the cornea of the subject.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充